Health Care · Pharmaceutical Preparations · Nasdaq · CIK 109657 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $0.31Day +1.99%Mkt cap $11M1Y −84.6%Off 52W high −85.4%Vol (1Y) 126.7%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,515 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest13.3% of sh out |
| Days to cover4.2d |
| 13F net flow (QoQ)+1.03% |
| Top-10 13F concentration82.5% |
| Next report (est.)2026-08-14 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$0 |
| Earnings (TTM)-$28.4M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−60.8% |
| 1Y−84.6% |
| 3Y−96.3% |
| 5Y−99.9% |
| 10Y−94.0% |
| Since incept. (ann.)−28.7% |
Total return through 2026-07-30 · series begins 2016-07-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)126.7% |
| Ann. volatility (3Y)138.4% |
| Sharpe (1Y)−0.89 |
| Sharpe (3Y)−0.26 |
| Max drawdown (1Y)−86.7% |
| Max drawdown (3Y)−97.2% |
| Beta (3Y vs SPY)0.43 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 451,875 | $184,365 | 1.43% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 294,459 | $120,170 | 0.93% | +1429.0% |
| VANGUARD FIDUCIARY TRUST CO | 225,938 | $92,183 | 0.72% | new |
| Arax Advisory Partners | 93,627 | $38,210 | 0.30% | new |
| CITADEL ADVISORS LLC | 66,165 | $27,002 | 0.21% | −18.1% |
| SeaCrest Wealth Management, LLC | 50,000 | $20,405 | 0.16% | +0.0% |
| UBS Group AG | 45,970 | $18,756 | 0.15% | +4596900.0% |
| TWO SIGMA SECURITIES, LLC | 31,796 | $12,976 | 0.10% | +153.7% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | −$0.11 | — | — | — |
| 2025-09-30 | 2025-11-14 | $1.04 | — | — | — |
| 2025-03-31 | 2025-05-15 | −$0.33 | — | — | — |
| 2024-09-30 | 2024-11-14 | −$1.53 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-14 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
